Your Source for Venture Capital and Private Equity Financings

DeepCure Grabs $24.6M Series A-1

2024-04-11
BOSTON, MA, DeepCure, a leader in developing novel, small molecule therapeutics powered by AI and automation of chemistry, announced today the closing of a $24.6 million Series A-1 financing.
The round was led by IAG Capital Partners (IAG) with participation from the company's current investors. DeepCure has raised more than $72 million in financing since its inception.

DeepCure was founded by researchers at MIT to accelerate breakthrough therapies using artificial intelligence (AI) and AI-enabling technologies to innovate small molecule discovery. The company is based in Boston, MA, and its engineers, chemists, and biologists collaborate on hard problems to find solutions that will have an enormous impact on patient health.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors